comparemela.com

Latest Breaking News On - Pieris pharmaceuticals trading down - Page 1 : comparemela.com

Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by Analysts at StockNews com

StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Trading Down 0.1 % Shares of PIRS stock opened at $10.48 on Thursday. Pieris Pharmaceuticals has a twelve month low of $10.31 and […]

Pieris Pharmaceuticals (NASDAQ:PIRS) Earns Hold Rating from Analysts at StockNews com

StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report report published on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Trading Down 7.2 % NASDAQ:PIRS opened at $0.24 on Friday. Pieris Pharmaceuticals has a 1-year low of $0.16 and a 1-year high […]

Pieris Pharmaceuticals, Inc Expected to Earn FY2027 Earnings of ($0 38) Per Share (NASDAQ:PIRS)

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Rating) – Equities researchers at Jefferies Financial Group issued their FY2027 earnings per share estimates for shares of Pieris Pharmaceuticals in a research note issued to investors on Wednesday, March 29th. Jefferies Financial Group analyst R. Song anticipates that the biotechnology company will post earnings per share of ($0.38) […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.